The global market for oxygen therapy and inhalation devices was valued at $1.0 billion in 2014. As analyzed in this detailed new report by LSI, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which will not only have important consequences in developed markets but could alter the competitive landscape in emerging markets. This report examines the global markets for these devices, which include stationary, ambulatory/portable, and transfilling oxygen concentrators; liquid oxygen systems; cylinders; dry powder inhalers; metered dose inhalers; nebulizers; and patient consumables.
Critical Issues Covered in this Report:
• The competitive landscape for these devices in the U.S. and international markets;
• Quantitative factors including pricing, replacement rates, and product sales; and
• Caseloads and other key infrastructure and market metrics.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
